No photo of Erkko Ylösmäki
20082024

Research activity per year

Network

Harri Alenius

Person: Teaching and research personnel, U4 Research and teaching staff

Eliisa Kekäläinen

Person: U3 Research and teaching staff

Johanna Arola

Person: U4 Research and teaching staff

Rui M. M. Branca

  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, ICMC
  • Univ Hosp Bern, University Hospital of Bern, University of Bern, Dept Cardiol, Swiss Cardiovasc Ctr Bern
  • Karolinska Institutet

External person

Sara Carpi

  • Univ Pisa, University of Pisa, Dept Pharm, Mol Pharmacol Lab

External person

Antonio Federico

  • Univ Siena, Sect Neurol Sci, Dept Neurol Neurosurg & Behav Sci
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Hlth Technol, Allergy Ctr
  • Univ Tampere, Tampere University, BioMediTech Inst, Fac Med & Life Sci
  • Tampere Univ, Tampere University, Prof Dario Grecos Grp
  • Tampere Univ, Tampere University, Finnish Hub Dev & Validat Integrated Approaches F
  • Tampere University
  • Tampere Univ, Tampere University, Fac Med & Hlth Technol, Finnish Hub Dev & Validat Integrated Approaches F
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Div Nephrol
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Dept Nephrol
  • Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth

External person

Beatrice Polini

  • Univ Pisa, University of Pisa, Dept Pharm, Mol Pharmacol Lab

External person

Janne Lehtio

  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, Dept Clin Neurosci, Div Psychol
  • Karolinska Inst, Karolinska Institutet, ICMC

External person

Paola Nieri

  • Univ Pisa, Dept Pharm
  • Univ Pisa, University of Pisa, Dept Pharm, Mol Pharmacol Lab

External person

Jeanette H.W. Leusen

  • Utrecht University Medical Center
  • University College Utrecht, Utrecht University, Utrecht, the Netherlands

External person

Yvonne Giannoula

  • Univ Helsinki, University of Helsinki, Translat Immunol Res Program, TRIMM
  • Univ Helsinki, University of Helsinki, Drug Res Program, Lab Immunovirotherapy, Fac Pharm

External person

Sari Tahka

  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

Tuuli Ranki

  • Targovax Oy
  • ValoTherapeut
  • Valo Therapeut Ltd

External person

Miika Martikainen

  • University of Eastern Finland (UEF)

External person

Firas Hamdan

  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

Ari Hinkkanen

  • University of Eastern Finland (UEF)

External person

Janne Lehtiö

  • Karolinska Institutet
  • Science for Life Laboratory

External person

Antti Ranniko

  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

Sari Pesonen

  • Targovax Oy, Dept Clin Sci
  • Valo Therapeut Ltd

External person

Antonella Romanini

  • Univ Hosp Pisa, University of Pisa, Azienda Ospedaliero Universitaria Pisana, Oncol Sect
  • Azienda Osped Univ Pisana, University of Pisa, Azienda Ospedaliero Universitaria Pisana, Med Oncol Unit
  • Univ Hosp Pisa, University of Pisa, Azienda Ospedaliero Universitaria Pisana, Med Oncol Unit

External person

Fadi. F. Hamdan

  • CHU St Justine Res Ctr, University of Montreal
  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp
  • Univ Naples Federico II, University of Naples Federico II, University of Naples Federico II, CIRFF

External person

Luigi Buonaguro

  • Ist Nazl Tumori IRCCS G Pascale, IRCCS Fondazione Pascale, Canc Immunoregulatory
  • Fdn Pascale IRCCS, IRCCS Fondazione Pascale, Innovat Immunol Models, Ist Nazl Studio & Cura Tumori

External person

Mikael von und zu Fraunberg

  • Kuopio University Hospital (KYS)

External person

Paul E. Brown

  • Monash University

External person

Talat Mokhtari-Azad

  • Univ Tehran Med Sci, Tehran University of Medical Sciences, Sch Publ Hlth, Dept Virol
  • Univ Tehran Med Sci, Tehran University of Medical Sciences, Res Ctr Clin Virol

External person

Maartje van Geenen

  • University of Eastern Finland (UEF)

External person

Juha E. Jääskeläinen

  • Kuopio University Hospital (KYS)

External person

Adriano Podesta

  • Univ Pisa, University of Pisa, Vet Teaching Hosp, Dept Vet Sci

External person

Marie Claude Bourgeois-Daigneault

  • Centre hospitalier de l’Université de Montréal
  • Université de Montréal

External person

Arto Immonen

  • Kuopio University Hospital (KYS)

External person

Gabriella Antignani

  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp
  • Univ Naples Federico II, University of Naples Federico II, University of Naples Federico II, CIRFF

External person

John C. Bell

  • Ottawa Hlth Res Inst, University of Ottawa, Ctr Innovat Canc Therapeut
  • Ottawa Hospital Research Institute

External person

Hanne Cojoc

  • Valo Therapeut Ltd

External person

Dara K. Mohammad

  • Salahaddin University / Institut Français du Proche-Orient, Erbil
  • Salahaddin Univ Erbil, Salahaddin University, Coll Agr, Dept Food Technol
  • Salahaddin Univ Erbil, Salahaddin University, Dept Forestry

External person

Henrik Paavilainen

  • University of Turku

External person

Petra Ahokas

  • Valo Therapeut Ltd

External person

Cristina Malorzo

  • Univ Helsinki, University of Helsinki, Drug Res Program, Lab Immunovirotherapy, Fac Pharm

External person

Markus Happala

  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

Julia Karbach

  • Krankenhaus NW Frankfurt, Hamatol Onkol
  • Krankenhaus NW Frankfurt, Krankenhaus Nordwest, Dept Oncol & Hematol

External person

Seppo Ylä-Herttuala

  • Kuopio University Hospital (KYS)
  • University of Eastern Finland (UEF)
  • University of Eastern Finland

External person

M. Medeot

  • Univ Padua, University of Padua, Dept Pharmaceut & Pharmacol Sci

External person

C. Boni

  • Ctr Psychiat & Neurosci, Institut National de la Sante et de la Recherche Medicale (Inserm), INSERM U894
  • INSERM, Institut National de la Sante et de la Recherche Medicale (Inserm), Ctr Psychiat & Neurosci, U984

External person

Oona Honkasalo

  • Univ Helsinki, University of Helsinki, Drug Res Program, Lab Immunovirotherapy, Fac Pharm

External person

Qing Wang

  • Karolinska University Hospital
  • Linkoping Univ, Linkoping University, NSC

External person

Tiina Siikanen

  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

Francesca Greco

  • Univ Naples Federico II, University of Naples Federico II, University of Naples Federico II, CIRFF
  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

L. Pastore

  • CEINGE Biotecnol Avanzate
  • Univ Helsinki, University of Helsinki, Inst Mol Med Finland, FIMM, Helsinki Inst Life Sci HiLIFE

External person

Susanna Koponen

  • Kuopio University Hospital (KYS)

External person

Arttu Uoti

  • Univ Helsinki, University of Helsinki, Translat Immunol Res Program, TRIMM

External person

Maria Tagliamonte

  • Ist Nazl Tumori IRCCS G Pascale, IRCCS Fondazione Pascale, Canc Immunoregulatory

External person

Petri Priha

  • Oncos Therapeutics Oy
  • Valo Therapeut Ltd

External person

Markus Vaha-Koskela

  • Univ Helsinki, University of Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program
  • Univ Helsinki, University of Helsinki, Inst Mol Med Finland, FIMM, Helsinki Inst Life Sci HiLIFE
  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

S. Carpi

  • Univ Pisa, University of Pisa, Istituto Nazionale di Fisica Nucleare, Dept Pharm

External person

Thomas Whalley

  • Cardiff Univ, Cardiff University, Sch Med, Inst Med Genet
  • Cardiff Univ, Cardiff University, Cardiff Sch Biosci

External person

Georgios Mermelekas

  • Karolinska Institutet
  • Science for Life Laboratory

External person

Manuela O. Gustafsson

  • Karolinska University Hospital

External person

Giovanni Castaldo

  • University of California, Berkeley

External person

Veijo Hukkanen

  • University of Turku

External person

Leena Ylösmäki

  • Valo Therapeut Ltd

External person

Husen M. Umer

  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, ICMC

External person

Alessandra Lopes

  • Universite catholique de Louvain

External person

Stefano Fogli

  • Univ Pisa, University of Pisa, Dept Clin & Expt Med

External person

Eliana Ruggiero

  • IRCCS San Raffaele, IRCCS Ospedale San Raffaele, IRCCS San Raffaele Pisana, Dept Med Sci

External person

Subhash Shrestha

  • University of Helsinki, Helsinki

External person

Sari Pesonen

  • Targovax Oy
  • Valo Therapeut Ltd

External person

Beatriz Martins

  • Univ Helsinki, University of Helsinki, Res Programmes Unit, Genome Scale Biol, Biomedicum Helsinki
  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp
  • Heart and Lung Centre HUCH and Helsinki University

External person

Matthew J. Vaughan

  • Valo Therapeut Ltd

External person

Gaëlle Vandermeulen

  • Universite catholique de Louvain

External person

Chiara Bonini

  • IRCCS San Raffaele, IRCCS Ospedale San Raffaele, IRCCS San Raffaele Pisana, Dept Med Sci
  • Paris VI, Institut National de la Sante et de la Recherche Medicale (Inserm), Institut National de la Sante et de la Recherche Medicale (Inserm), Paris & EPAR UMR S UPMC, INSERM, EPAR U707

External person

C. I. Edvard Smith

  • Karolinska University Hospital

External person

Christianne Groeneveldt

  • Leiden Univ, Leiden University, Fac Sci, Translat Epidemiol

External person

Raul Andino

  • University of California Davis, University of California System, Ctr Biophoton

External person

F. Frascaro

  • Univ Siena, University of Siena

External person

Elke Jäger

  • Krankenhaus NW Frankfurt, Krankenhaus Nordwest, Dept Oncol & Hematol

External person

Barbara Szomolay

  • Imperial College London
  • Cardiff Univ, Cardiff University, Sch Med, Inst Med Genet
  • Cardiff University School of Medicine
  • Cardiff Univ, Cardiff University, Cardiff Sch Biosci

External person

Marta Medeot

  • Univ Padua, University of Padua, Dept Pharmaceut & Pharmacol Sci

External person

L Pastore

  • Univ Napoli Federico II, University of Naples Federico II, Dipartimento Med Mol & Biotecnol Med

External person

Seppo Yla-Herttuala

  • University of Eastern Finland (UEF)
  • Univ Eastern Finland, University of Eastern Finland, Biobank Eastern Finland

External person

Minna Niittykoski

  • University of Eastern Finland (UEF)

External person